The effect of anticancer agent induced gastrointestinal damage on drug absorption
| Project/Area Number |
25860125
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
TSUJII Kazunari
YOTSUMOTO Keiichi
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Keywords | 消化管障害 / 5-FU / ダビガトラン / 抗癌剤 / 体内動態 / アルミニウム定量法 / 難吸収性マーカー |
|---|
| Outline of Final Research Achievements |
We evaluated the effects of 5-FU induced gastrointestinal damage on dabigatran pharmacokinetics(PK) and pharmacodynamics(PD) in rats. After oral administration of DABE, the PK parameters of Cmax and AUC of DAB in the 5-FU group were decreased by 30% compared to that of control group. Moreover, the PD parameter of activated partial thromboplastin time (aPTT) in the 5-FU group was also reduced. We concluded that intensive monitoring of DABE PK/PD under treatment with 5-FU is required.
|
Report
(3 results)
Research Products
(1 results)
